General Information of Drug (ID: DMXTV1B)

Drug Name
6-phenylpyridazin-3-yl thiophene-2-carboxylate
Synonyms CHEMBL1253380; AC1O4BXS; 6-phenylpyridazin-3-yl thiophene-2-carboxylate; MolPort-002-097-410; HMS1597J02; ZINC1059557; BDBM50326574; MCULE-6134548476; (6-phenylpyridazin-3-yl) thiophene-2-carboxylate
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 282.3
Logarithm of the Partition Coefficient (xlogp) 3.3
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C15H10N2O2S
IUPAC Name
(6-phenylpyridazin-3-yl) thiophene-2-carboxylate
Canonical SMILES
C1=CC=C(C=C1)C2=NN=C(C=C2)OC(=O)C3=CC=CS3
InChI
InChI=1S/C15H10N2O2S/c18-15(13-7-4-10-20-13)19-14-9-8-12(16-17-14)11-5-2-1-3-6-11/h1-10H
InChIKey
WIJDBDCYFCOSHK-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
6403448
TTD ID
D04MZK

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MIF messenger RNA (MIF mRNA) TT6804T MIF_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40.